Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C. (Q43034608)
Jump to navigation
Jump to search
scientific article published in May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C. |
scientific article published in May 2011 |
Statements
1 reference
Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C. (English)
1 reference
1 reference
Stefan Zeuzem
1 reference
Alexandra Doehring
1 reference
Wolf Peter Hofmann
1 reference
Christina Schlecker
1 reference
Christoph Sarrazin
1 reference
Tobias Müller
1 reference
Eva Herrmann
1 reference
Gerd Geisslinger
1 reference
1 May 2011
1 reference
1 reference
21
1 reference
5
1 reference
289-296
1 reference
Identifiers
1 reference
1 reference